Literature DB >> 19160026

Size effect of PLGA spheres on drug loading efficiency and release profiles.

G J S Dawes1, L E Fratila-Apachitei, K Mulia, I Apachitei, G-J Witkamp, J Duszczyk.   

Abstract

Drug delivery systems (DDS) based on poly (lactide-co-glycolide) (PLGA) microspheres and nanospheres have been separately studied in previous works as a means of delivering bioactive compounds over an extended period of time. In the present study, two DDS having different sizes of the PLGA spheres were compared in morphology, drug (dexamethasone) loading efficiency and drug release kinetics in order to investigate their feasibility with regard to production of medical combination devices for orthopedic applications. The loaded PLGA spheres have been produced by the oil-in-water emulsion/solvent evaporation method following two different schemes. Their morphology was assessed by scanning electron microscopy and the drug release was monitored in phosphate buffer saline solution at 37 degrees C for 550 h using high performance liquid chromatography. The synthesis schemes used produced spheres with two different and reproducible size ranges (20 +/- 10 and 1.0 +/- 0.4 microm) having a smooth outer surface and regular shape. The drug loading efficiency of the 1.0 microm spheres was found to be 11% as compared to just 1% for the 20 microm spheres. Over the 550 h release period, the larger spheres (diameter 20 +/- 10 microm) released 90% of the encapsulated dexamethasone in an approximately linear fashion whilst the relatively small spheres (diameter 1.0 +/- 0.4 microm) released only 30% of the initially loaded dexamethasone, from which 20% within the first 25 h. The changes observed were mainly attributed to the difference in surface area between the two types of spheres as the surface texture of both systems was visibly similar. As the surface area per unit volume increases in the synthesis mixture, as is the case for the 1.0 microm spheres formulation, the amount of polymer-water interfaces increases allowing more dexamethasone to be encapsulated by the emerging polymer spheres. Similarly, during the release phase, as the surface area per unit volume increases, the rate of inclusion of water into the polymer increases, permitting faster diffusion of dexamethasone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19160026     DOI: 10.1007/s10856-008-3666-0

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  14 in total

1.  In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices.

Authors:  T Hickey; D Kreutzer; D J Burgess; F Moussy
Journal:  J Biomed Mater Res       Date:  2002-08

Review 2.  Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles.

Authors:  Ugo Bilati; Eric Allémann; Eric Doelker
Journal:  Eur J Pharm Biopharm       Date:  2005-04       Impact factor: 5.571

3.  Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles.

Authors:  Saowanee Jaraswekin; Sompol Prakongpan; Roland Bodmeier
Journal:  J Microencapsul       Date:  2007-03       Impact factor: 3.142

4.  Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.

Authors:  Carolina Gómez-Gaete; Nicolas Tsapis; Madeleine Besnard; Amélie Bochot; Elias Fattal
Journal:  Int J Pharm       Date:  2006-11-12       Impact factor: 5.875

5.  Clinical outcomes of dexamethasone-eluting stent implantation in ST-elevation acute myocardial infarction.

Authors:  Santiago Jimenez-Valero; Belen Santos; Fernando Pajin; Tomas Canton; Esther Lazaro; Jose Moreu; Gonzalo Hernandez; Luis Rodriguez Padial
Journal:  Catheter Cardiovasc Interv       Date:  2007-10-01       Impact factor: 2.692

6.  Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering.

Authors:  Diederik H R Kempen; Lichun Lu; Teresa E Hefferan; Laura B Creemers; Avudaiappan Maran; Kelly L Classic; Wouter J A Dhert; Michael J Yaszemski
Journal:  Biomaterials       Date:  2008-05-09       Impact factor: 12.479

7.  Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.

Authors:  Marcus Jäger; Johannes Fischer; Wiebke Dohrn; Xinning Li; David C Ayers; Akos Czibere; Wolf Christian Prall; Sabine Lensing-Höhn; Rüdiger Krauspe
Journal:  J Orthop Res       Date:  2008-11       Impact factor: 3.494

8.  Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels.

Authors:  J Liu; S M Zhang; P P Chen; L Cheng; W Zhou; W X Tang; Z W Chen; C M Ke
Journal:  J Mater Sci Mater Med       Date:  2007-08-01       Impact factor: 3.896

9.  In vitro biocompatibility of bioresorbable polymers: poly(L, DL-lactide) and poly(L-lactide-co-glycolide).

Authors:  A A Ignatius; L E Claes
Journal:  Biomaterials       Date:  1996-04       Impact factor: 12.479

10.  The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres.

Authors:  Guobao Wei; Glenda J Pettway; Laurie K McCauley; Peter X Ma
Journal:  Biomaterials       Date:  2004-01       Impact factor: 12.479

View more
  19 in total

1.  Nanospheres delivering the EGFR TKI AG1478 promote optic nerve regeneration: the role of size for intraocular drug delivery.

Authors:  Rebecca Robinson; Stephen R Viviano; Jason M Criscione; Cicely A Williams; Lin Jun; James C Tsai; Erin B Lavik
Journal:  ACS Nano       Date:  2011-06-09       Impact factor: 15.881

2.  Targeted Nanodelivery of Drugs and Diagnostics.

Authors:  Margaret A Phillips; Martin L Gran; Nicholas A Peppas
Journal:  Nano Today       Date:  2010-04-01       Impact factor: 20.722

3.  Release of PLGA-encapsulated dexamethasone from microsphere loaded porous surfaces.

Authors:  G J S Dawes; L E Fratila-Apachitei; B S Necula; I Apachitei; G J Witkamp; J Duszczyk
Journal:  J Mater Sci Mater Med       Date:  2009-08-11       Impact factor: 3.896

4.  Sustained low-dose dexamethasone delivery via a PLGA microsphere-embedded agarose implant for enhanced osteochondral repair.

Authors:  Robert M Stefani; Andy J Lee; Andrea R Tan; Saiti S Halder; Yizhong Hu; X Edward Guo; Aaron M Stoker; Gerard A Ateshian; Kacey G Marra; James L Cook; Clark T Hung
Journal:  Acta Biomater       Date:  2019-12-02       Impact factor: 8.947

5.  Effect of fabrication parameters on morphology and drug loading of polymer particles for rosiglitazone delivery.

Authors:  Madeline R Spetz; Christopher Isely; R Michael Gower
Journal:  J Drug Deliv Sci Technol       Date:  2021-07       Impact factor: 5.062

6.  Surface Functionalization of Polymer Particles for Cell Targeting by Modifying Emulsifier Chemistry.

Authors:  Christopher Isely; Kidochukwu J Atube; Candice V Cheung; Christine F Steege; Perry J Pellechia; R Michael Gower
Journal:  ACS Appl Polym Mater       Date:  2022-03-16

7.  Fabrication of biodegradable particles with tunable morphologies by the addition of resveratrol to oil in water emulsions.

Authors:  Christopher Isely; Alexandra C Stevens; Gregory L Tate; John R Monnier; R Michael Gower
Journal:  Int J Pharm       Date:  2020-10-03       Impact factor: 5.875

8.  Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months.

Authors:  Filis Kazazi-Hyseni; Mariana Landin; Audrey Lathuile; Gert J Veldhuis; Sima Rahimian; Wim E Hennink; Robbert Jan Kok; Cornelus F van Nostrum
Journal:  Pharm Res       Date:  2014-05-14       Impact factor: 4.200

9.  Synthesis and Characterization of a Fe3O4@PNIPAM-Chitosan Nanocomposite and Its Potential Application in Vincristine Delivery.

Authors:  Cynthia N Hernández-Téllez; Ana G Luque-Alcaraz; Maribel Plascencia-Jatomea; Hiram J Higuera-Valenzuela; Mabeth Burgos-Hernández; Nadia García-Flores; Mario E Álvarez-Ramos; Jorge L Iriqui-Razcon; Pedro A Hernández-Abril
Journal:  Polymers (Basel)       Date:  2021-05-23       Impact factor: 4.329

Review 10.  Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review.

Authors:  Yabing Hua; Yuhuai Su; Hui Zhang; Nan Liu; Zengming Wang; Xiang Gao; Jing Gao; Aiping Zheng
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.